Upgrade to SI Premium - Free Trial

Corbus Pharmaceuticals (CRBP) PT Lowered to $52 at Oppenheimer

June 17, 2026 6:02 AM
(Updated - June 17, 2026 6:03 AM EDT)

Oppenheimer analyst Jeff Jones lowered the price target on Corbus Pharmaceuticals ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change